Clinical Trial Update: Urinary Tract Infection Study With the Antibiotic Levofloxacin Given at a Higher Dose Over a Shorter Period of Time [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating a higher-dose, shorter-duration levofloxacin regimen for complicated urinary tract infection was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Urinary Tract Infection

Drugs mentioned

• Levofloxacin (Levofloxacin)

Snippet

Sponsor: University of Manitoba | Conditions: Complicated Urinary Infection | Phase 4 | Status: TERMINATED